THIS IS AN UPDATE ABOUT THE RACE to be first to market a vaccine to prevent cervical cancer. Merck & Co. is currently in the lead. On October 6, 2005, Merck released results of a trial that is part of a phase III study of its vaccine, called GARDASIL™ (a “quadrivalent human papillomavirus types 6, […]
- "Health Technology Update"
Cervical Cancer Vaccine Trial Generates Huge Headlines
Because of its potential to prevent cancer, HPV vaccine is closely-watched by media
- By Robert Michel
- > From the Volume XII No. 15 - October 24, 2005 Issue
- Tags: dark report, lab test, lab tests, the dark report
